FDA Inspection 1331710 — Matthew J. Frigault, MD

Matthew J. Frigault, MD — FEI 3044448909

The FDA completed an inspection of Matthew J. Frigault, MD on Aug 7, 2026 in Boston, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Aug 7, 2026
Fiscal Year
2026
Product Type
Biologics
Project Area
Bioresearch Monitoring
Location
Boston, MA (United States)

Additional Details

Clinical Investigator (CI)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.